Human Oncogenes & Tumor Suppressor Genes
Enumerates known oncogenes and tumor suppressors, with corresponding genetic alterations and cellular effects.
Akt Signaling Pathway
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
Akt | Point mutation, amplification, increased expression | ![]() |
||||
![]() |
Bax | Point mutation | ![]() |
||||
![]() |
FKHR/FoxO | Translocation | ![]() |
||||
![]() |
PI3K | Point mutation | ![]() |
||||
![]() |
Bcl2 | Translocation | ![]() |
||||
![]() |
INPP4B | Deletion, loss of heterozygosity, reduced expression | |||||
![]() |
LKB1 | Point mutation | ![]() |
![]() |
|||
![]() |
PTEN | Point mutation, deletion | ![]() |
||||
![]() |
TSC1/TSC2 | Point mutation | ![]() |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



Cell Cycle Control: G1/S Checkpoint
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
Abl | Translocation | ![]() |
||||
![]() |
Cdk-2 | Amplification, increased expression | ![]() |
||||
![]() |
Cdk-4 | Point mutation | ![]() |
||||
![]() |
Cyclin D | Amplification, translocation | ![]() |
||||
![]() |
Cyclin E | Amplification | ![]() |
||||
![]() |
HPV-E7 | Viral Infection | ![]() |
||||
![]() |
p15 | Point mutation | ![]() |
||||
![]() |
p16 | Point mutation | ![]() |
||||
![]() |
p57 | Point mutation | ![]() |
||||
![]() |
Rb | Point mutation | ![]() |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



Cell Cycle Control: G2/M DNA Damage Checkpoint
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
Aurora A | Amplification, increased expression | ![]() |
||||
![]() |
HPV-E6 | Viral Infection | ![]() |
||||
![]() |
Mdm2 | Amplification | ![]() |
||||
![]() |
ARF | Point mutation | ![]() |
||||
![]() |
ATM/ATR | Point mutation | ![]() |
||||
![]() |
BRCA1 | Point mutation | ![]() |
![]() |
|||
![]() |
Chk1 | Point mutation | ![]() |
||||
![]() |
Chk2 | Point mutation | ![]() |
||||
![]() |
DNA-PK | Point mutation | ![]() |
||||
![]() |
FANCs | Point mutation | ![]() |
||||
![]() |
HIPK2 | Point mutation | ![]() |
![]() |
|||
![]() |
NBS1 | Point mutation, deletion | ![]() |
||||
![]() |
p53 | Point mutation, deletion | ![]() |
![]() |
|||
![]() |
WT1 | Point mutation, deletion | |||||
![]() |
MUTYH | Point mutation, deletion | |||||
![]() |
BLM | Point mutation, deletion | |||||
![]() |
RECQL4 | Point mutation, deletion | |||||
![]() |
WRN | Deletion, insertion | |||||
![]() |
MMR genes | Point mutation, reduced expression | |||||
![]() |
XPA, C, D | Point mutation | |||||
![]() |
FBXW7 | Point mutation |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



Death Receptor Signaling Pathway
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
Fas | Point mutation | ![]() |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



GPCR
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
Ga | Point mutation | ![]() |
||||
![]() |
GPCR | Point mutation | ![]() |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



Hedgehog Signaling In Vertebrates
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
Gli | Amplification, translocation | ![]() |
![]() |
|||
![]() |
Hedgehog | Point mutation | ![]() |
![]() |
|||
![]() |
Smo | Point mutation | ![]() |
![]() |
|||
![]() |
Ptch | Point mutation | ![]() |
![]() |
|||
![]() |
Su(Fu) | Point mutation | ![]() |
![]() |
|||
![]() |
EXT1,2 | Point mutation, deletion, insertion | ![]() |
![]() |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



Notch Signaling Pathway
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
Notch | Translocation | ![]() |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



Ras
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
B-Raf | Point mutation, amplification, increased expression | ![]() |
||||
![]() |
Fos/Jun | Increased expression | ![]() |
![]() |
|||
![]() |
ILK | Increased expression | ![]() |
![]() |
|||
![]() |
Ras | Point mutation | ![]() |
||||
![]() |
RTKs | Point mutation, translocation, amplification, increased expression | ![]() |
![]() |
![]() |
![]() |
|
![]() |
Integrin | Deletion | ![]() |
||||
![]() |
NF1 | Point mutation, deletion | ![]() |
||||
![]() |
NF2 | Point mutation, deletion | ![]() |
![]() |
|||
![]() |
VHL | Point mutation | ![]() |
||||
![]() |
FH | Point mutation | |||||
![]() |
SDH | Point mutation, deletion |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



TGF-β Signaling Pathway
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
Myc | Point mutation, amplification | ![]() |
||||
![]() |
BMPR | Point mutation | ![]() |
||||
![]() |
Smad2/3 | Point mutation | ![]() |
||||
![]() |
Smad4 | Point mutation | ![]() |
||||
![]() |
TGFβR | Point mutation | ![]() |
||||
![]() |
MEN1 | Point mutation | ![]() |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



Wnt/β-Catenin Signaling
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
β-catenin | Point mutation | ![]() |
||||
![]() |
RAR | Amplification | ![]() |
||||
![]() |
SOX | Amplification, increased expression | ![]() |
||||
![]() |
Wnt1 | Increased expression | ![]() |
||||
![]() |
APC | Point mutation | ![]() |
||||
![]() |
Axin | Point mutation | ![]() |
||||
![]() |
α-catenin | Point mutation | ![]() |
||||
![]() |
E-cadherin | Point mutation | ![]() |
![]() |
![]() |
||
![]() |
Wnt5A | Point mutation | ![]() |
||||
![]() |
GPC3 | Deletions, point mutation | ![]() |
||||
![]() |
HRPT2 | Point mutation | ![]() |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function



Other / TFs
Protein | Genetic Alterations |
Evading Apoptosis |
Self-Suffciency in Growth Status |
Insensitivity to Anti-Growth Signals |
Tissue Invasion & Metastasis |
Sustained Angiogenesis |
|
---|---|---|---|---|---|---|---|
![]() |
TAL1 | Translocation | ![]() |
||||
![]() |
MLL | Translocation | ![]() |
||||
![]() |
HOXs | Translocation, point mutation | ![]() |
||||
![]() |
MITF | Amplification | ![]() |
![]() |
|||
![]() |
EVI1 | Translocation | ![]() |
||||
![]() |
BCL6 | Translocation, point mutation | |||||
![]() |
HPC1 | Point mutation |
Table Key:
Oncogenes
Tumor Suppressors
Indicates Protein Function


